Related Experiment Videos
[Interventional treatment for partial stenosis or occlusion type of Budd-Chiari syndrome]
Insights
Interventional management using angioplasty and stenting effectively treated Budd-Chiari syndrome patients with hepatic vein or inferior vena cava issues. Procedures were successful, relieving symptoms with no severe side effects observed during follow-up.
Area of Science:
- Interventional Radiology
- Vascular Surgery
- Hepatology
Context:
- Budd-Chiari syndrome presents challenges in managing hepatic vein and inferior vena cava stenosis or occlusion.
- Interventional techniques are crucial for treating complex vascular conditions affecting the liver.
Purpose:
- To evaluate the efficacy and safety of interventional procedures for Budd-Chiari syndrome.
- To assess outcomes of percutaneous transluminal angioplasty (PTA) and vascular stenting in managing hepatic vein and inferior vena cava involvement.
Summary:
- Twelve patients with partial stenosis or occlusion of Budd-Chiari syndrome underwent interventional treatment involving puncture, PTA, and vascular stent placement.
- All procedures were technically successful, leading to symptom resolution or relief in all patients.
- Follow-up over an average of 8.5 months (1.5-26 months) demonstrated gratifying early and mid-term results with no severe adverse events.
Impact:
- This study highlights the effectiveness of interventional radiology in managing complex Budd-Chiari syndrome cases.
- Successful interventions can significantly improve patient outcomes and quality of life.
- Emphasizes the importance of skilled operators and thorough anatomical knowledge for safe and effective treatment.
Abstract:
It is difficult to deal with interventional management of partial stenosis or occlusion type of Budd-chiari syndrome and manage the hepatic veins associated with inferior vena cave occlusion. Puncture, PTA and vascular stent plant were used to treat 12 patients with partial stenosis or occlusion of Budd-chiari syndrome. The procedures were successful. Either the symptoms or signs disappeared or relieved after operation. No severe side effects occurred. Follow-up for 1.5 through 26 months (average 8.5 months) revealed that the early or middle results were gratifying. There may be danger during operation, but perfect skills and adequate clinical anatomic knowledge help avoid severe side effects.